Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B-RECON: Preserved vs Preservative-free Saline for Botox Reconstitution in Chronic Migraine
NCT03698409Phase 4Completed
- Sponsor
- Upstate Medical University
- Start
- Jan 2019
- Primary completion
- Aug 2019
- Modality
- Injectable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bacteriostatic sodium chloride in chronic migraine (2 arms), sponsored by Upstate Medical University. Primary endpoint: Verbal Pain Scale. Started Jan 2019; status: completed.
02
Drugs
bacteriostatic sodium chloride
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT03698409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03698409.